Given that aberrant cytoskeletal remodeling is implicated in multiple neurodevelopmental disorders [43,44,45,46], these findings suggest that the ErbB2–Dock7 signaling axis may represent a common pathway through which distinct genetic alterations converge to produce similar cellular outcomes. This evidence concerns the gene ERBB2 and neurodevelopmental disorder.